drugset / Trial / NCT00505063

Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

NCT00505063

Phase 2 Completed 76 enrolled Memorial Sloan Kettering Cancer Center
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study will look at your body's response to the new immunizations. We want to see how well they will protect you. Immunization is the same as vaccination. Our goal is to protect you as much as we can. We do not want you to have the measles, mumps, or whooping cough. We are doing the study because there is no standard way to re-immunize people after cancer treatments.

Timeline

Start
2007-07-10
Primary completion
2025-06-11
Completion
2025-06-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Boostrix Vaccine
Subject Gardasil Vaccine
Subject Hepatitis B Vaccine
Subject Hib Unknown
Subject Immunization Schedule patients > or = to 7 years and <11 years of age Unknown
Subject Measles, mumps, rubella, MMR Unknown
Subject Menactra Vaccine
Subject Pediarix Vaccine
Subject Prevnar 13 Vaccine
Subject Varivax Vaccine
Subject inactivated polio virus vaccine Unknown